Cell News and Research

RSS

NIH awards NeoStem a GO grant to investigate the potential of stem cells in regenerating bone

NeoStem, Inc. (NYSE Amex: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need and holder of the exclusive, worldwide license to VSEL(TM) Technology that uses very small embryonic-like stem cells isolated from peripheral blood, announced today that it has been awarded a grant of $108,746 for the repair of bone defects by human stem cells under the American Recovery and Reinvestment Act (RRA) of 2009 from the National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS) of the National Institutes of Health (NIH).

7 Oct 2009

Low levels of ROS might protect us from diabetes, says study

We've all heard about the damage that reactive oxygen species (ROS) - aka free radicals - can do to our bodies and the sales pitches for antioxidant vitamins, skin creams or "superfoods" that can stop them. In fact, there is considerable scientific evidence that chronic ROS production within cells can contribute to human diseases, including insulin resistance and type 2 diabetes.

7 Oct 2009

New findings on Alzheimer's disease suggest a possible way for treatment

The action of a small protein that is a major villain in Alzheimer's disease can be counterbalanced with another brain protein, researchers at UT Southwestern Medical Center have found in an animal study.

7 Oct 2009

Commercial shipments of ImageStreamX imaging flow cytometers begin

Amnis Corporation, a manufacturer of advanced cell imaging systems, today announced the first commercial shipments of the new ImageStreamX imaging flow cytometers. The new instrument - the second generation of Amnis' patented ImageStream® technology - combines the speed, sensitivity, and phenotyping abilities of flow cytometry with the detailed imagery, rich feature set, and functional insights of microscopy.

7 Oct 2009

Measures taken by Memorial Blood Centers to stay prepared for the spread of H1N1 virus

Memorial Blood Centers today outlined steps the organization is taking to stay prepared for the spread of the H1N1 virus and to ensure a safe experience for blood donors and an ample blood supply for our communities.

7 Oct 2009

Aeolus Pharmaceuticals raises $1.65 million from existing institutional shareholders

Aeolus Pharmaceuticals, Inc. announced today that it has completed a $1.65 million financing with several existing institutional shareholders, all of which are affiliates of Xmark Opportunity Partners, LLC. Under the terms of the financing, Aeolus received $1.65 million in gross proceeds in exchange for 5,892,857 Units (the “Units”), with each Unit comprised of one share of Aeolus Pharmaceuticals common stock, and a seven year warrant to purchase up to two additional shares of Aeolus Pharmaceuticals common stock at an initial exercise price of $0.28 per share, for a per Unit purchase price of $0.28.

7 Oct 2009

Mobile phones may help in kicking nicotine habit

Hooked on your cell phone and cigarettes? Fortunately, your mobile device could help you kick the nicotine habit, according to a new review from New Zealand.

7 Oct 2009

Pro-Pharmaceuticals closes $325,000 tranche of private placement; total raised to $3.8 million

Pro-Pharmaceuticals, Inc. (OTCBB: PRWP) (the “Company”), today announced that it has closed a $325,000 tranche of a private placement of up to $6.0 million with 10X Fund, L.P., which is purchasing unregistered Series B convertible preferred stock and warrants. This tranche brings the total raised to date to approximately $3.8 million.

7 Oct 2009

FDA provides 510(k) clearance for Boston Scientific's WallFlex Biliary RX covered stents

Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its WallFlex(®) Biliary RX fully and partially covered stents for the palliative treatment of malignant bile duct strictures. The WallFlex Biliary RX uncovered stent was cleared by the FDA in 2006.

6 Oct 2009

pDCs promote growth and survival of malignant myeloma cells

Multiple myeloma cancer cells thwart many of the drugs used against them by causing nearby cells to turn traitor - to switch from defending the body against disease to shielding the myeloma cells from harm - Dana-Farber Cancer Institute scientists report in the October issue of Cancer Cell.

6 Oct 2009

iMedicor to market Access Pharmaceuticals' MuGard in North America

ACCESS PHARMACEUTICALS, INC. announced today that it had signed an agreement with iMedicor for the North American commercial launch of MuGard, its FDA approved mucoadhesive oral rinse for the management of oral mucositis and stomatitis caused by radiotherapy and/or chemotherapy.

6 Oct 2009

NovImmune wins the 2009 EUROPEAN BIOTECHNICA AWARD

The winner of the 2009 EUROPEAN BIOTECHNICA AWARD is NovImmune SA from Switzerland. This biopharmaceutical company duly receives the lion’s share of the €100,000 prize money, which is awarded each year by Deutsche Messe AG and its partners. The aim of the award is to celebrate the achievements of innovative European companies in the field of biotechnology and the life sciences.

6 Oct 2009

LMA Stonebreaker and Holmium Lasers to feature at 27th World Congress on Endourology

Continuing to drive innovation in endourology, Cook Medical will feature a series of product demonstrations and interactive presentations with a special emphasis on kidney stone management solutions, including the LMA Stonebreaker and Holmium Lasers at the 27th Annual World Congress on Endourology and SWL (shock wave lithotripsy) at the Sheraton Grand Hotel in Munich, Germany from 6-10 October.

6 Oct 2009

Lady Foot Locker's initiative for breast cancer awareness

In support of Breast Cancer Awareness Month, Lady Foot Locker reaches out to women of all ages with a collection of fashionable "pink" products. Touting messages of hope and inspiration, the line supports the efforts of the American Cancer Society (ACS).

6 Oct 2009

Promising alternative to use of live animals for drug testing

International Stem Cell Corporation, the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, announces positive results of its collaboration with Absorption Systems to study ISCO’s stem-cell-derived human corneal tissue as an alternative to live animals for drug testing.

6 Oct 2009

Ingenuity Systems, Millennium Science announce a multi-year deal for Ingenuity Pathway Analysis with QFAB

Ingenuity Systems, the leading provider of information solutions for life science researchers, and Millennium Science, Ingenuity Systems' exclusive distributor for Australia and New Zealand, today announced a multi-year deal for Ingenuity Pathway Analysis (IPA) with the Queensland Facility for Advanced Bioinformatics (QFAB).

6 Oct 2009

UCSF's Elizabeth Blackburn receives Nobel Prize in Medicine, lauded by Speaker Nancy Pelosi

Speaker Nancy Pelosi issued the following statement congratulating molecular biologist Elizabeth H. Blackburn of the University of California, San Francisco, who today was named to receive the 2009 Nobel Prize in Medicine. Dr. Blackburn shares the award with Carol W. Greider of Johns Hopkins University School of Medicine and Jack W. Szostak of Harvard Medical School for their discovery of an enzyme that plays a key role in normal cell function, as well as in cell aging and most cancers.

6 Oct 2009

St. Jude Children’s Research Hospital researcher receives the Millipore Guava Flow Cytometry Award

Millipore Corporation, a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today awarded Dr. Mari Hashitate Dallas of St. Jude Children’s Research Hospital in Memphis, Tenn., the Millipore Guava® Flow Cytometry Award.

6 Oct 2009

Fred Hutchinson Cancer Research Center receives 60 research grants totaling nearly $40.4 million

Scientists at Fred Hutchinson Cancer Research Center have been awarded 60 research grants totaling nearly $40.4 million under the American Recovery & Reinvestment Act of 2009. The totals reflect data available as of Oct. 1 and reported by the National Institutes of Health.

6 Oct 2009

Vivaldi receives US patent for live attenuated influenza vaccines

Vivaldi Biosciences Inc. (Vivaldi), a biotechnology company focused on development of vaccines for influenza, today announced that the United States Patent and Trademark Office has issued US Patent 7,588,768 covering live attenuated influenza vaccines (LAIVs) with modifications to the viral NS1 gene, and methods for producing the vaccines in cell culture systems.

6 Oct 2009

Cell News and Research

NIH awards NeoStem a GO grant to investigate the potential of stem cells in regenerating bone

Low levels of ROS might protect us from diabetes, says study

New findings on Alzheimer's disease suggest a possible way for treatment

Commercial shipments of ImageStreamX imaging flow cytometers begin

Measures taken by Memorial Blood Centers to stay prepared for the spread of H1N1 virus

Aeolus Pharmaceuticals raises $1.65 million from existing institutional shareholders

Mobile phones may help in kicking nicotine habit

Pro-Pharmaceuticals closes $325,000 tranche of private placement; total raised to $3.8 million

FDA provides 510(k) clearance for Boston Scientific's WallFlex Biliary RX covered stents

pDCs promote growth and survival of malignant myeloma cells

iMedicor to market Access Pharmaceuticals' MuGard in North America

NovImmune wins the 2009 EUROPEAN BIOTECHNICA AWARD

LMA Stonebreaker and Holmium Lasers to feature at 27th World Congress on Endourology

Lady Foot Locker's initiative for breast cancer awareness

Promising alternative to use of live animals for drug testing

Ingenuity Systems, Millennium Science announce a multi-year deal for Ingenuity Pathway Analysis with QFAB

UCSF's Elizabeth Blackburn receives Nobel Prize in Medicine, lauded by Speaker Nancy Pelosi

St. Jude Children’s Research Hospital researcher receives the Millipore Guava Flow Cytometry Award

Fred Hutchinson Cancer Research Center receives 60 research grants totaling nearly $40.4 million

Vivaldi receives US patent for live attenuated influenza vaccines

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News